Business Description
Healius Ltd
ISIN : AU0000033359
Share Class Description:
ASX:HLS: Ordinary SharesDescription
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.54 | |||||
| Debt-to-EBITDA | -2.38 | |||||
| Interest Coverage | 2.24 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.09 | |||||
| Beneish M-Score | -3.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.6 | |||||
| 3-Year EPS without NRI Growth Rate | -57.6 | |||||
| 3-Year FCF Growth Rate | 1.7 | |||||
| 3-Year Book Growth Rate | -5.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 22.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.95 | |||||
| 9-Day RSI | 39.17 | |||||
| 14-Day RSI | 40.36 | |||||
| 6-1 Month Momentum % | -26.45 | |||||
| 12-1 Month Momentum % | -54.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.53 | |||||
| Quick Ratio | 0.47 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 57.08 | |||||
| Days Sales Outstanding | 35.21 | |||||
| Days Payable | 337.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2.9 | |||||
| Shareholder Yield % | -10.31 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.07 | |||||
| Operating Margin % | 4.3 | |||||
| Net Margin % | -57.63 | |||||
| FCF Margin % | 12.82 | |||||
| ROE % | -66.47 | |||||
| ROA % | -27.26 | |||||
| ROIC % | 1.99 | |||||
| ROC (Joel Greenblatt) % | -78.4 | |||||
| ROCE % | -32.47 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 20.75 | |||||
| PS Ratio | 0.39 | |||||
| PB Ratio | 0.76 | |||||
| Price-to-Free-Cash-Flow | 3.07 | |||||
| Price-to-Operating-Cash-Flow | 2.35 | |||||
| EV-to-EBIT | -2.46 | |||||
| EV-to-Forward-EBIT | 17.51 | |||||
| EV-to-EBITDA | -3.48 | |||||
| EV-to-Forward-EBITDA | 6.71 | |||||
| EV-to-Revenue | 1.4 | |||||
| EV-to-Forward-Revenue | 1.31 | |||||
| EV-to-FCF | 10.73 | |||||
| Price-to-Projected-FCF | 0.2 | |||||
| Price-to-Median-PS-Value | 0.35 | |||||
| Earnings Yield (Greenblatt) % | -40.69 | |||||
| FCF Yield % | 25.98 | |||||
| Forward Rate of Return (Yacktman) % | 9.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Healius Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 1,691.8 | ||
| EPS (TTM) (A$) | -1.621 | ||
| Beta | 0.99 | ||
| Volatility % | 43.8 | ||
| 14-Day RSI | 40.36 | ||
| 14-Day ATR (A$) | 0.05025 | ||
| 20-Day SMA (A$) | 1.22425 | ||
| 12-1 Month Momentum % | -54.15 | ||
| 52-Week Range (A$) | 1.08 - 3.022021 | ||
| Shares Outstanding (Mil) | 726.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Healius Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Healius Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Healius Ltd Frequently Asked Questions
What is Healius Ltd(ASX:HLS)'s stock price today?
The current price of ASX:HLS is A$1.15. The 52 week high of ASX:HLS is A$3.02 and 52 week low is A$1.08.
When is next earnings date of Healius Ltd(ASX:HLS)?
The next earnings date of Healius Ltd(ASX:HLS) is 2024-08-29 Est..
Does Healius Ltd(ASX:HLS) pay dividends? If so, how much?
Healius Ltd(ASX:HLS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers